Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LanJuan Li

Showing results (1-10 of 860) with videos related to

Pageof 86
Sort By:
Zhonghua Nei Ke Za Zhi|June 18, 2015
[More strive to explore the interaction mechanism between intestine dyshomeostasis and severe liver diseases]Lanjuan Li
Science China. Life Sciences|February 15, 2014
Suggestions to the hepatitis B vaccine eventsLanJuan Li
Infectious Microbes & Diseases|June 6, 2025
Translation: Expert Consensus on the Application of Artificial Liver Blood Purification System in the Treatment of Severe and Critical COVID-19: National Clinical Research Center for Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious DiseasesLanjuan Li
Stem Cell Research & Therapy|October 19, 2019
The application of resveratrol to mesenchymal stromal cell-based regenerative medicineChenxia Hu, Lanjuan Li
Artificial Organs|April 6, 2019
State of the art-Artificial liver in ChinaYimin Zhang, Lanjuan Li
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 2, 2021
Corrigendum to "Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus"Ruiqi Tang, Lanjuan Li
Cellular & Molecular Immunology|August 8, 2017
CD4<sup>+</sup>CD25<sup>+</sup> regulatory T-cells: a potential target for treating patients with chronic HBV infectionJiezuan Yang, Lanjuan Li
Journal of Cellular and Molecular Medicine|March 17, 2017
Pre-conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusionChenxia Hu, Lanjuan Li
Journal of Molecular Medicine (Berlin, Germany)|June 15, 2019
Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failureChenxia Hu, Lanjuan Li
Trends in Microbiology|April 14, 2015
Who determines the outcomes of HBV exposure?Baohong Wang, Lanjuan Li
Pageof 86

Showing results (1-10 of 860) with videos related to

Sort By:
Pageof 86
Zhonghua Nei Ke Za Zhi|June 18, 2015
[More strive to explore the interaction mechanism between intestine dyshomeostasis and severe liver diseases]Lanjuan Li
Science China. Life Sciences|February 15, 2014
Suggestions to the hepatitis B vaccine eventsLanJuan Li
Infectious Microbes & Diseases|June 6, 2025
Translation: Expert Consensus on the Application of Artificial Liver Blood Purification System in the Treatment of Severe and Critical COVID-19: National Clinical Research Center for Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious DiseasesLanjuan Li
Stem Cell Research & Therapy|October 19, 2019
The application of resveratrol to mesenchymal stromal cell-based regenerative medicineChenxia Hu, Lanjuan Li
Artificial Organs|April 6, 2019
State of the art-Artificial liver in ChinaYimin Zhang, Lanjuan Li
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|July 2, 2021
Corrigendum to "Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus"Ruiqi Tang, Lanjuan Li
Cellular & Molecular Immunology|August 8, 2017
CD4<sup>+</sup>CD25<sup>+</sup> regulatory T-cells: a potential target for treating patients with chronic HBV infectionJiezuan Yang, Lanjuan Li
Journal of Cellular and Molecular Medicine|March 17, 2017
Pre-conditions for eliminating mitochondrial dysfunction and maintaining liver function after hepatic ischaemia reperfusionChenxia Hu, Lanjuan Li
Journal of Molecular Medicine (Berlin, Germany)|June 15, 2019
Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failureChenxia Hu, Lanjuan Li
Trends in Microbiology|April 14, 2015
Who determines the outcomes of HBV exposure?Baohong Wang, Lanjuan Li
Pageof 86